Rice L - Search Results

1

Randomized phase II trial of bevacizumab plus everolimus versus bevacizumab alone for recurrent or persistent ovarian, fallopian tube or peritoneal carcinoma: An NRG oncology/gynecologic oncology group study.

Tew WP, Sill MW, Walker JL, Secord AA, Bonebrake AJ, Schilder JM, Stuckey A, Rice L, Tewari KS, Aghajanian CA. Tew WP, et al. Among authors: rice l. Gynecol Oncol. 2018 Nov;151(2):257-263. doi: 10.1016/j.ygyno.2018.08.027. Epub 2018 Aug 31. Gynecol Oncol. 2018. PMID: 30177462 Free PMC article. Clinical Trial.

2

The impact of perioperative β blocker use on patient outcomes after primary cytoreductive surgery in high-grade epithelial ovarian carcinoma.

Al-Niaimi A, Dickson EL, Albertin C, Karnowski J, Niemi C, Spencer R, Shahzad MM, Uppal S, Saha S, Rice L, Nally AM. Al-Niaimi A, et al. Among authors: rice l. Gynecol Oncol. 2016 Dec;143(3):521-525. doi: 10.1016/j.ygyno.2016.09.019. Epub 2016 Sep 29. Gynecol Oncol. 2016. PMID: 27693123

3

International Gynecologic Cancer Society (IGCS) 2016: Meeting report.

Del Carmen MG, Rice LW. Del Carmen MG, et al. Gynecol Oncol. 2017 Jan;144(1):11-15. doi: 10.1016/j.ygyno.2016.11.016. Epub 2016 Nov 12. Gynecol Oncol. 2017. PMID: 27847107 No abstract available.

4

Combination chemotherapy in advanced adenocarcinoma of the fallopian tube.

Muntz HG, Tarraza HM, Goff BA, Granai GO, Rice LW, Nikrui N, Fuller AF Jr. Muntz HG, et al. Among authors: rice lw. Gynecol Oncol. 1991 Mar;40(3):268-73. doi: 10.1016/0090-8258(90)90290-2. Gynecol Oncol. 1991. PMID: 2013452

5

Racial and ethnic enrollment disparities in clinical trials of poly(ADP-ribose) polymerase inhibitors for gynecologic cancers.

Wagar MK, Mojdehbakhsh RP, Godecker A, Rice LW, Barroilhet L. Wagar MK, et al. Among authors: rice lw. Gynecol Oncol. 2022 Apr;165(1):49-52. doi: 10.1016/j.ygyno.2022.01.032. Epub 2022 Feb 8. Gynecol Oncol. 2022. PMID: 35144798

6

Surgical stage IV endometrial carcinoma: a study of 47 cases.

Goff BA, Goodman A, Muntz HG, Fuller AF Jr, Nikrui N, Rice LW. Goff BA, et al. Among authors: rice lw. Gynecol Oncol. 1994 Feb;52(2):237-40. doi: 10.1006/gyno.1994.1038. Gynecol Oncol. 1994. PMID: 8314145

7

The clinical trials crisis in gynecologic oncology.

Del Carmen MG, Annunziata CM, Rice LW. Del Carmen MG, et al. Gynecol Oncol. 2017 Jun;145(3):481-482. doi: 10.1016/j.ygyno.2017.04.003. Epub 2017 Apr 11. Gynecol Oncol. 2017. PMID: 28410755 No abstract available.

8

Expanding the pipeline. The 2018 Society of Gynecologic Oncology presidential address.

Rice LW. Rice LW. Gynecol Oncol. 2018 Jun;149(3):435-438. doi: 10.1016/j.ygyno.2018.04.559. Epub 2018 May 3. Gynecol Oncol. 2018. PMID: 29729931 No abstract available.

9

Thirty-day unplanned hospital readmission in ovarian cancer patients undergoing primary or interval cytoreductive surgery: systematic literature review.

Clark RM, Rice LW, Del Carmen MG. Clark RM, et al. Gynecol Oncol. 2018 Aug;150(2):370-377. doi: 10.1016/j.ygyno.2018.06.009. Gynecol Oncol. 2018. PMID: 29929923 Review.

10

Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease.

Goff BA, Sainz de la Cuesta R, Muntz HG, Fleischhacker D, Ek M, Rice LW, Nikrui N, Tamimi HK, Cain JM, Greer BE, Fuller AF Jr. Goff BA, et al. Among authors: rice lw. Gynecol Oncol. 1996 Mar;60(3):412-7. doi: 10.1006/gyno.1996.0065. Gynecol Oncol. 1996. PMID: 8774649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,005 results

Search Page

Filters